A stabilized GHRH(1-44) analog studied for growth-hormone-axis and lipid metabolism.

| Compound | Tesamorelin |
| Also known as | TH9507 |
| CAS Number | 218949-48-5 |
| Molecular Weight | 5,135.9 g/mol |
| Sequence / Form | Stabilized GHRH(1-44) |
| Classification | Endocrine research compound |
| Appearance | Lyophilized powder |
| Purity | ≥99% (HPLC · MS-verified) |
| Storage | 2–8°C; -20°C for long-term |
| Intended Use | Research Use Only |
Tesamorelin is a stabilized analog of the full-length growth-hormone-releasing hormone GHRH(1-44). As a GHRH-receptor agonist it is studied for stimulation of endogenous growth-hormone secretion and downstream IGF-1 signaling.
Research models also examine its relationship to visceral-lipid and metabolic endpoints associated with the GH–IGF-1 axis.
Every Ethos Bio lot of Tesamorelin is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry through our third-party testing partner, Janoshik Analytical. A signed Certificate of Analysis documenting identity and ≥99% purity is provided for every lot.
Independent third-party HPLC & mass-spec verification. The COA shipped with your order reflects your specific lot.
What is Tesamorelin?
Tesamorelin is a stabilized GHRH(1-44) analog studied for growth-hormone-axis stimulation and IGF-1 signaling in research models. It is a research-use-only compound.
How is Tesamorelin different from Sermorelin?
Tesamorelin is based on the longer GHRH(1-44) sequence with stabilizing modifications, while Sermorelin is the GHRH(1-29) fragment; both are GHRH-receptor agonists used as research tools.
What is Tesamorelin's molecular weight?
Tesamorelin has an approximate molecular weight of 5,135.9 g/mol and CAS number 218949-48-5.